Lassman Law+Policy was recognized by U.S. News & World Report as one of the Best Law Firms in Washington, D.C. in the areas of FDA Law and Administrative/Regulatory Law for 2020. This is the first time the firm has been recognized on this prestigious list.
Chambers USA recently recognized Scott M. Lassman as a leading attorney (Band 2) in the category of Healthcare: Pharmaceutical/Medical Products Regulatory. Chambers USA specifically highlighted his ability to provide practical solutions to complex regulatory issues, his efficiency, and his "deep knowledge of Hatch-Waxman."
Scott M. Lassman recently was recognized by The Best Lawyers in America as one of the leading lawyers in America in the categories of FDA Law and Administrative/Regulatory Law.
Best Lawyers' recognitions are based purely on the feedback received from lawyers already highlighted in the publication.
Lassman Law+Policy recently was honored by LMG Life Sciences by being placed on its "Shortlist" of Regulatory Firms to Watch in 2019. Lassman Law+Policy is the only boutique firm specializing in FDA regulatory law to be recognized in that category. Congratulations to the other nominees: Akin Gump, Debevoise & Plimpton, and Mayer Brown!
LMG Life Sciences evaluates attorneys on the basis of case evidence, peer feedback and client feedback.
Scott Lassman recently was honored by Chambers USA: America’s Leading Lawyers for Business. Mr. Lassman was named a Ranked Lawyer for 2019 in the area of Pharmaceutical/Medical Products Regulatory law.
The Chambers rankings are determined by independent research into a range of qualities and evidence of an attorney's work.